TENAX THERAPEUTICS, INC. Peo Actually Paid Comp Amt
TENAX THERAPEUTICS, INC. (TENX) reported Peo Actually Paid Comp Amt of $21.67 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-22.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-22
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $21.67M DEF 14A · filed 2026-04-22 |
| 2024-12-31 | $7.70M DEF 14A · filed 2026-04-22 |
| 2023-12-31 | $515.68K DEF 14A · filed 2026-04-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |